BioSpace News Archive

Medical Imaging Software Market - Know the prominent factors that will help in reshaping the market growth

Medical imaging software encompasses technologies and other solutions for various imaging modalities and processes to image a body for the purpose of diagnosis and treatment of diseases.

January 10, 2022
·
5 min read
Tendinitis Treatment Market: Achilles Tendinitis Segment to Dominate Global Market

Tendon is the name given to a fibrous and denser tissue that helps connect the bone to the fleshy muscle and helps in movement to occur simultaneously in the bone and muscle, which aids in walking, bending, and rotation of the muscles and bones.

January 10, 2022
·
6 min read
Business

Avalo Therapeutics Appoints Stephen Smolinski as Chief Commercial Officer

Avalo Therapeutics, Inc. announced the appointment of Stephen Smolinski as Chief Commercial Officer, effective January 3, 2022.

January 10, 2022
·
6 min read
Pharm Country

Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock

Celsion Corporation, a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced that it has entered into a securities purchase agreement with certain institutional investors to purchase 50,000 shares of Series A convertible redeemable preferred stock and 50,000 shares of Series B convertible redeemable preferred stock.

January 10, 2022
·
6 min read
Biotech Bay

ASC Therapeutics and Professor Steven W. Pipe Publish Expert Review on Novel Gene Therapies of Hemophilia A

Second-generation gene therapies can increase protein synthesis and secretion.

January 10, 2022
·
5 min read
Deals

Idorsia receives US FDA approval of QUVIVIQ (daridorexant) 25 and 50 mg for the treatment of adults with insomnia

Allschwil, Switzerland– January10, 2022 Idorsia Ltd announced that the US Food and Drug Administration has approved QUVIVIQ™ 25 mg and 50 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance1.

January 10, 2022
·
15 min read
Angle PLC Announces Insight into Drug Resistance in NSCLC

ANGLE plc is pleased to announce that the world-class research team led by Prof. Evi Lianidou at the National and Kapodistrian University of Athens, has published results of a further study undertaken in non-small cell lung cancer patients with an EGFR mutation being treated with the tyrosine kinase inhibitor.

January 10, 2022
·
9 min read
Genetown

NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets

NANOBIOTIX provided a corporate update highlighting key priorities and anticipated development milestones for 2022.

January 10, 2022
·
14 min read
MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference

MorphoSys AG, announced that Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, will present at the 40 th Annual J.P. Morgan Healthcare Conference on Wednesday January 12, 2022 at 5:15 p.m. EST.

January 10, 2022
·
3 min read
Medivir to present at the H.C. Wainwright BioConnect Virtual Conference

Medivir AB announces that the company will present at the virtual meeting H.C. Wainwright BioConnect Virtual Conference, January 10-13.

January 10, 2022
·
1 min read